CPT2 and glioblastoma: Carnitine palmitoyltransferase 2 (CPT2) is highly expressed in recurrent GBM, and its involvement in mitochondrial fatty acid oxidation with macrophage‐driven phagocytosis of CD47 contributes to a poor prognosis [39].